Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 10, 2019
Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors: a systematic literature review
Daniel P Hart, Charles R M Hay, Ri Liesner, et al.
Haematologica
|
September 30, 2018
Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A
Daniel P Hart, Nazmiye Uzun, Stuart Skelton, et al.
Nature Reviews. Disease Primers
|
June 25, 2021
Haemophilia
Erik Berntorp, Kathelijn Fischer, Daniel P Hart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 2, 2021
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey
Paul Batty, Anne Riddell, Steve Kitchen, et al.
British Journal of Haematology
|
November 20, 2012
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization
Peter W Collins, Elizabeth Chalmers, Daniel P Hart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 23, 2021
Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC
Wolfgang Miesbach, Pratima Chowdary, Michiel Coppens, et al.
Thrombosis and Haemostasis
|
June 12, 2015
Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A
Paul Batty, Gary W Moore, Sean Platton, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 9, 2018
Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study
Martin J Scott, Hua Xiang, Daniel P Hart, et al.
Haematologica
|
August 15, 2009
Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice
Shao-An Xue, Liquan Gao, Sharyn Thomas, et al.
Blood
|
October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses
Karl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 10, 2019
Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors: a systematic literature review
Daniel P Hart, Charles R M Hay, Ri Liesner, et al.
Haematologica
|
September 30, 2018
Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A
Daniel P Hart, Nazmiye Uzun, Stuart Skelton, et al.
Nature Reviews. Disease Primers
|
June 25, 2021
Haemophilia
Erik Berntorp, Kathelijn Fischer, Daniel P Hart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 2, 2021
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey
Paul Batty, Anne Riddell, Steve Kitchen, et al.
British Journal of Haematology
|
November 20, 2012
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization
Peter W Collins, Elizabeth Chalmers, Daniel P Hart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 23, 2021
Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC
Wolfgang Miesbach, Pratima Chowdary, Michiel Coppens, et al.
Thrombosis and Haemostasis
|
June 12, 2015
Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A
Paul Batty, Gary W Moore, Sean Platton, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 9, 2018
Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study
Martin J Scott, Hua Xiang, Daniel P Hart, et al.
Haematologica
|
August 15, 2009
Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice
Shao-An Xue, Liquan Gao, Sharyn Thomas, et al.
Blood
|
October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses
Karl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
Page
of 5